APA (7th ed.) Citation

N, D., B, B., C, P., E, G., N, B., MO, C., . . . C, P. (2026). HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: Results from the phase II DREP-HAPLO trial. Haematologica, 111(7), 2377. https://doi.org/10.3324/haematol.2025.300013

Chicago Style (17th ed.) Citation

N, Dhedin, et al. "HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease: Results from the Phase II DREP-HAPLO Trial." Haematologica 111, no. 7 (2026): 2377. https://doi.org/10.3324/haematol.2025.300013.

MLA (9th ed.) Citation

N, Dhedin, et al. "HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease: Results from the Phase II DREP-HAPLO Trial." Haematologica, vol. 111, no. 7, 2026, p. 2377, https://doi.org/10.3324/haematol.2025.300013.